Published in Kidney Int on April 01, 2003
TGF-β sequestration by mesangial cell integrin αvβ8: A novel mechanism of glomerular endothelial cell regulation. Am J Pathol (2011) 0.78
Nephron-deficient Fvb mice develop rapidly progressive renal failure and heavy albuminuria involving excess glomerular GLUT1 and VEGF. Lab Invest (2009) 0.77
Interactions between growth factors in the kidney: implications for progressive renal injury. Kidney Int (2003) 0.75
Src family kinases in chronic kidney disease. Am J Physiol Renal Physiol (2017) 0.75
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med (2006) 19.09
Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. N Engl J Med (2011) 11.11
Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol (2006) 6.64
Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT). Diabetes Care (2008) 3.45
Second symposium on the definition and management of anaphylaxis: summary report--second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. Ann Emerg Med (2006) 3.00
Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial. Lancet (2010) 2.55
Avosentan for overt diabetic nephropathy. J Am Soc Nephrol (2010) 2.32
Albuminuria response to very high-dose valsartan in type 2 diabetes mellitus. J Hypertens (2007) 2.12
Podocyte-specific expression of angiopoietin-2 causes proteinuria and apoptosis of glomerular endothelia. J Am Soc Nephrol (2007) 2.06
The SAZA study: implementing health financing reform in South Africa and Zambia. Health Policy Plan (2003) 2.00
Angiopoietin-1 therapy enhances fibrosis and inflammation following folic acid-induced acute renal injury. Kidney Int (2008) 1.70
Rituximab therapy for the type B syndrome of severe insulin resistance. N Engl J Med (2004) 1.62
Valsartan improves arterial stiffness in type 2 diabetes independently of blood pressure lowering. Hypertension (2008) 1.60
Prevalence and concomitants of glucose intolerance in European obese children and adolescents. Diabetes Care (2003) 1.58
Effects of rosiglitazone, glyburide, and metformin on β-cell function and insulin sensitivity in ADOPT. Diabetes (2011) 1.53
Comparison between digital panoramic radiography and cone-beam computed tomography for the identification of the mandibular canal as part of presurgical dental implant assessment. J Oral Maxillofac Surg (2008) 1.49
Endotracheal tube cuff pressures in patients intubated before transport. Am J Emerg Med (2009) 1.46
Fatal human herpesvirus-6 infection after renal transplantation. Transplantation (2009) 1.41
Effect of rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes. J Clin Endocrinol Metab (2009) 1.41
Detection and partial characterisation of two antibacterial factors from the excretions/secretions of the medicinal maggot Lucilia sericata and their activity against methicillin-resistant Staphylococcus aureus (MRSA). Microbes Infect (2004) 1.39
Aortic pulse wave velocity and albuminuria in patients with type 2 diabetes. J Am Soc Nephrol (2005) 1.31
Maggot therapy: the science and implication for CAM part II-maggots combat infection. Evid Based Complement Alternat Med (2006) 1.29
Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes. Diabetes (2009) 1.25
Helicopter emergency medical services for adults with major trauma. Cochrane Database Syst Rev (2013) 1.22
The longevity of Caenorhabditis elegans in soil. Biol Lett (2005) 1.22
Keepin' it R.E.A.L.!: program description and results of baseline assessment. Health Educ Behav (2002) 1.22
Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice. Diabetes (2008) 1.21
The impact of population-based identification of chronic kidney disease using estimated glomerular filtration rate (eGFR) reporting. Nephrol Dial Transplant (2007) 1.20
Primary care-based disease management of chronic kidney disease (CKD), based on estimated glomerular filtration rate (eGFR) reporting, improves patient outcomes. Nephrol Dial Transplant (2007) 1.19
Assessing glycemic control in patients with diabetes and end-stage renal failure. Am J Kidney Dis (2003) 1.19
Prevention of chronic kidney and vascular disease: toward global health equity--the Bellagio 2004 Declaration. Kidney Int Suppl (2005) 1.16
Microalbuminuria and cardiovascular risk. Am J Hypertens (2004) 1.14
Effect of various diuretic treatments on rosiglitazone-induced fluid retention. J Am Soc Nephrol (2006) 1.13
Dynamic Contrast-enhanced MR Imaging Curve-type Analysis: Is It Helpful in the Differentiation of Prostate Cancer from Healthy Peripheral Zone? Radiology (2015) 1.11
Serum heat shock protein 27 and diabetes complications in the EURODIAB prospective complications study: a novel circulating marker for diabetic neuropathy. Diabetes (2008) 1.11
Intracellular cytokine production by dengue virus-specific T cells correlates with subclinical secondary infection. J Infect Dis (2011) 1.08
The role of PC-1 and ACE genes in diabetic nephropathy in type 1 diabetic patients: evidence for a polygenic control of kidney disease progression. Nephrol Dial Transplant (2002) 1.08
Roles of angiopoietins in kidney development and disease. J Am Soc Nephrol (2008) 1.07
Mechanical stretch induces monocyte chemoattractant activity via an NF-kappaB-dependent monocyte chemoattractant protein-1-mediated pathway in human mesangial cells: inhibition by rosiglitazone. J Am Soc Nephrol (2005) 1.04
Promoting universal financial protection: contracting faith-based health facilities to expand access--lessons learned from Malawi. Health Res Policy Syst (2013) 1.03
Mechanical forces in diabetic kidney disease: a trigger for impaired glucose metabolism. J Am Soc Nephrol (2007) 1.02
Renal function in type 2 diabetes with rosiglitazone, metformin, and glyburide monotherapy. Clin J Am Soc Nephrol (2011) 1.01
Pneumomediastinum after shallow water diving. J Emerg Med (2007) 1.00
What is the maximum time that a unit of red blood cells can be safely left out of controlled temperature storage? Transfus Med Rev (2011) 0.99
Atherosclerosis in type 2 diabetes mellitus and insulin resistance: mechanistic links and therapeutic targets. J Diabetes Complications (2002) 0.99
Protecting resources for primary health care under fiscal federalism: options for resource allocation. Health Policy Plan (2007) 0.98
Effect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression: PREMIER. Hypertension (2003) 0.98
Mechanical forces and TGFbeta1 reduce podocyte adhesion through alpha3beta1 integrin downregulation. Nephrol Dial Transplant (2009) 0.98
Targeted glomerular angiopoietin-1 therapy for early diabetic kidney disease. J Am Soc Nephrol (2013) 0.98
A role for TRPV1 in influencing the onset of cardiovascular disease in obesity. Hypertension (2012) 0.98
General practitioner workforce planning: assessment of four policy directions. BMC Health Serv Res (2010) 0.95
Short-term oral folic acid supplementation enhances endothelial function in patients with type 2 diabetes. Am J Hypertens (2005) 0.94
Rosiglitazone decreases C-reactive protein to a greater extent relative to glyburide and metformin over 4 years despite greater weight gain: observations from a Diabetes Outcome Progression Trial (ADOPT). Diabetes Care (2009) 0.94
The distribution of GPs in Ireland in relation to deprivation. Health Place (2010) 0.94
A multicenter comparison of established and emerging cardiac biomarkers for the diagnostic evaluation of chest pain in the emergency department. Am Heart J (2011) 0.93
Albuminuria is associated with too few glomeruli and too much testosterone. Kidney Int (2013) 0.93
The virtual advisor program: linking students to mentors via the world wide web. Acad Emerg Med (2004) 0.93
Proteinuria in diabetes: bystander or pathway to cardiorenal disease? J Am Soc Nephrol (2010) 0.93
Maggot Therapy: The Science and Implication for CAM Part I-History and Bacterial Resistance. Evid Based Complement Alternat Med (2006) 0.92
Stretch reduces nephrin expression via an angiotensin II-AT(1)-dependent mechanism in human podocytes: effect of rosiglitazone. Am J Physiol Renal Physiol (2009) 0.92
Serum lipids and the progression of nephropathy in type 1 diabetes. Diabetes Care (2006) 0.92
Gene gun bombardment-mediated expression and translocation of EGFP-tagged GLUT4 in skeletal muscle fibres in vivo. Pflugers Arch (2002) 0.91
Endothelial factors and diabetic nephropathy. Diabetes Care (2011) 0.91
Pioglitazone improves in vitro viability and function of endothelial progenitor cells from individuals with impaired glucose tolerance. PLoS One (2012) 0.90
Modification of gibberellin signalling (metabolism & signal transduction) in sugar beet: analysis of potential targets for crop improvement. Transgenic Res (2008) 0.90
An electromyographic assessment of the "bear hug": an examination for the evaluation of the subscapularis muscle. Arthroscopy (2008) 0.89
Effect of renin-angiotensin system blockade on soluble Klotho in patients with type 2 diabetes, systolic hypertension, and albuminuria. Clin J Am Soc Nephrol (2013) 0.89
Conversion of platelets from a proaggregatory to a proinflammatory adhesive phenotype: role of PAF in spatially regulating neutrophil adhesion and spreading. Blood (2007) 0.89
Fluorescence-based sensing of glucose using engineered glucose/galactose-binding protein: a comparison of fluorescence resonance energy transfer and environmentally sensitive dye labelling strategies. Biochem Biophys Res Commun (2007) 0.89
GLUT-1 overexpression: Link between hemodynamic and metabolic factors in glomerular injury? Hypertension (2003) 0.89
An ongoing role of α-calcitonin gene-related peptide as part of a protective network against hypertension, vascular hypertrophy, and oxidative stress. Hypertension (2014) 0.89
Circulating vascular progenitor cells in patients with type 1 diabetes and microalbuminuria. Diabetes Care (2010) 0.88
Standardized antibacterial honey (Medihoney) with standard therapy in wound care: randomized clinical trial. J Adv Nurs (2009) 0.87
Impaired glucose tolerance in obese children and adolescents. N Engl J Med (2002) 0.87
The antibacterial activity against MRSA strains and other bacteria of a <500Da fraction from maggot excretions/secretions of Lucilia sericata (Diptera: Calliphoridae). Microbes Infect (2007) 0.87
Nurse-led psychological interventions to improve diabetes control: assessing competencies. Patient Educ Couns (2010) 0.87
Glucose induces increases in levels of the transcriptional repressor Id2 via the hexosamine pathway. Am J Physiol Endocrinol Metab (2005) 0.86
VEGF and angiopoietins in diabetic glomerulopathy: how far for a new treatment? Metabolism (2012) 0.85
HDL composition predicts new-onset cardiovascular disease in patients with type 1 diabetes. Diabetes Care (2007) 0.85
Effects of high dose aleglitazar on renal function in patients with type 2 diabetes. Int J Cardiol (2010) 0.84
N-3 PUFA increase bioavailability and function of endothelial progenitor cells. Food Funct (2014) 0.83
Helicopter emergency medical services for adults with major trauma. Cochrane Database Syst Rev (2015) 0.82
Comparison of depressive symptoms in type 2 diabetes using a two-stage survey design. Psychosom Med (2013) 0.82
Modernising morning report: innovation in teaching and learning. Clin Teach (2010) 0.82
Multidetector CT of emergent biliary pathologic conditions. Radiographics (2013) 0.81
Ultrasound- and MR-guided focused ultrasound surgery for prostate cancer. World J Radiol (2012) 0.81
Peroxisome proliferator-activated receptor-γ agonist rosiglitazone prevents albuminuria but not glomerulosclerosis in experimental diabetes. Am J Nephrol (2010) 0.81
Targeting albumin excretion rate in the treatment of the hypertensive diabetic patient with renal disease. J Am Soc Nephrol (2005) 0.81